Pfizer Slashes Outlook for 2023 Amid Lower Covid-19 Revenue
Shares of Pfizer, the healthcare giant, fell 3.5% to $31.00 in after-hours trading as the company significantly reduced its outlook for the year. The revision is primarily driven by expectations…